ArticlePloS one2013

Plasminogen activator inhibitor-2 polymorphism associates with recurrent coronary event risk in patients with high HDL and C-reactive protein levels.

James P Corsetti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.